The Cytokines IL-21 and GM-CSF Have Opposing Regulatory Roles in the Apoptosis of Conventional Dendritic Cells  by Wan, Chi-Keung et al.
Immunity
ArticleThe Cytokines IL-21 and GM-CSF
Have Opposing Regulatory Roles
in the Apoptosis of Conventional Dendritic Cells
Chi-Keung Wan,1 Jangsuk Oh,1 Peng Li,1 Erin E. West,1 Elizabeth A. Wong,1 Allison B. Andraski,1 Rosanne Spolski,1
Zu-Xi Yu,2 Jianping He,3 Brian L. Kelsall,3 and Warren J. Leonard1,*
1Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute
2Pathology Core, National Heart, Lung, and Blood Institute
3Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases
National Institutes of Health, Bethesda, MD 20892-1674, USA
*Correspondence: wjl@helix.nih.gov
http://dx.doi.org/10.1016/j.immuni.2013.02.011SUMMARY
Interleukin-21 (IL-21) has broad actions on T and B
cells, but its actions in innate immunity are poorly
understood. Here we show that IL-21 induced
apoptosis of conventional dendritic cells (cDCs) via
STAT3 and Bim, and this was inhibited by granulo-
cyte-macrophage colony-stimulating factor (GM-
CSF). ChIP-Seq analysis revealed genome-wide
binding competition between GM-CSF-induced
STAT5 and IL-21-induced STAT3. Expression of
IL-21 in vivo decreased cDC numbers, and this was
prevented by GM-CSF. Moreover, repetitive a-galac-
tosylceramide injection of mice induced IL-21 but
decreased GM-CSF production by natural killer
T (NKT) cells, correlating with decreased cDC
numbers. Furthermore, adoptive transfer of wild-
type CD4+ T cells caused more severe colitis with
increased DCs and interferon-g (IFN-g)-producing
CD4+ T cells in Il21r/Rag2/ mice (which lack
T cells and have IL-21-unresponsive DCs) than in
Rag2/ mice. Thus, IL-21 and GM-CSF exhibit
cross-regulatory actions on gene regulation and
apoptosis, regulating cDC numbers and thereby the
magnitude of the immune response.
INTRODUCTION
Interleukin-21 (IL-21) is a pleiotropic type I cytokine that signals
via IL-21R and the common cytokine receptor g chain, gc (Spol-
ski and Leonard, 2008). gc is also an essential component of the
receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 (Leonard and Spol-
ski, 2005) and is mutated in humans with X-linked severe
combined immunodeficiency (XSCID) (Noguchi et al., 1993). IL-
21 is primarily produced by CD4+ T cells and natural killer
T (NKT) cells, but it acts on multiple lineages, including T cells,
B cells, natural killer (NK) cells, NKT cells, and bone-marrow-
derived dendritic cells (BMDCs) (Spolski and Leonard, 2008).
Among its actions, IL-21 is a comitogen for T cells, cooperates514 Immunity 38, 514–527, March 21, 2013 ª2013 Elsevier Inc.with IL-7 or IL-15 to expand CD8+ T cells (Zeng et al., 2005),
promotes the differentiation of T follicular helper (Tfh) cells (Nur-
ieva et al., 2008) and T helper 17 (Th17) cells (Korn et al., 2007;
Nurieva et al., 2007; Zhou et al., 2007), and has potent antitumor
activity (Hinrichs et al., 2008; Ma et al., 2003; Wang et al., 2003;
Zeng et al., 2005). IL-21 also promotes B cell differentiation to Ig-
producing plasma cells through its induction of BLIMP1 (Kwon
et al., 2009; Ozaki et al., 2004), a transcription factor critical for
plasma cell formation (Martins and Calame, 2008). Interestingly,
IL-21 also induces BCL6 (Ozaki et al., 2004) and drives T follicular
cell differentiation (Nurieva et al., 2008; Vogelzang et al., 2008).
IL-21 cooperates with IL-4 for Ig class switching particularly to
IgG1 and IgG3 (Ozaki et al., 2002; Pe`ne et al., 2004), and defec-
tive signaling by IL-21 and IL-4 appears to explain the B cell
defect in humans with XSCID (Ozaki et al., 2002). IL-21 signaling
is mediated in part via its activation of JAK1 and JAK3, which in
turn activate STAT3, which is a major mediator of IL-21 signaling
(Spolski and Leonard, 2008).
As compared to its actions on T and B cells, the role(s) of IL-21
in innate immunity are less well studied. IL-21 increases cyto-
toxic activity of NK and NKT cells, but its proliferative effect on
these cells is stage-dependent (Spolski and Leonard, 2008).
Previously, it was shown that the maturation and subsequent
activation of granulocyte-macrophage colony-stimulating factor
(GM-CSF)-induced bone-marrow-derived DCs (GMCSF-DCs)
are inhibited by IL-21, with diminished production of the proin-
flammatory cytokines IL-1b, IL-6, and TNF-a (Brandt et al.,
2003). We now show that IL-21 potently induces apoptosis of
conventional DCs (cDCs) but only has a modest effect on plas-
macytoid DCs (pDCs). The apoptotic effect on cDCs depended
on STAT3 and Bim and was reversed by GM-CSF. These
opposing actions of IL-21 and GM-CSF on cDCsmight therefore
influence the maintenance of immune tolerance versus the acti-
vation of an effective immune response.
RESULTS
IL-21 Induces Apoptosis of Splenic but Not GM-CSF-
Induced DCs
Previously, in vitro activation and maturation of GMCSF-DCs
was shown to be inhibited by IL-21 (Brandt et al., 2003). To inves-
tigate the actions of IL-21 on these GMCSF-DCs as well as on
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monocytes (Liu et al., 2009; Naik et al., 2006) and in which the
effect of IL-21 has not been reported, we first compared the
effect of IL-21 on cell viability of splenic DCs (which include
cDCs and pDCs) and GMCSF-DCs. IL-21 alone or in combina-
tion with LPS or CpG did not alter the viability of GMCSF-DCs
(Figure 1A). In contrast, it potently decreased viability of splenic
DCs (Figure 1B). Interestingly, the addition of LPS or CpG, which
signal via toll-like receptors (TLRs) (Medzhitov, 2001) slightly
diminished this effect (Figure 1B).
Splenic DCs can be divided into B220CD11chi cDCs and
B220+CD11cint pDCs. cDCs reside in lymphoid tissues and
process self-antigen to maintain immune tolerance, and after
encountering foreign antigens, they mature and initiate immune
responses (Shortman and Naik, 2007), whereas pDCs trigger
innate immunity by producing type I IFNs upon stimulation by
viruses or TLR ligands (Asselin-Paturel et al., 2001). Interestingly,
whereas IL-21 decreased the percentage (Figure 1C, panel vi
versus i) and absolute number (Figure 1D) of cDCs, it increased
the relative percentage of pDCs. GM-CSF almost completely in-
hibited this effect (Figure 1C, panels vii versus vi; Figure 1D),
whereas IL-3, which like GM-CSF shares the common b chain,
bc, as part of its receptor, as well as Flt3L and IL-4 had only
modest effects (Figure 1C, panels viii–x versus vi; Figure 1D).
Correspondingly, IL-21 decreased viability and induced apo-
ptosis of cDCs and this was reversed by GM-CSF (Figure 1E).
IL-3 partially reversed IL-21-induced apoptosis (Figure 1E),
consistent with its modest effect on viability (Figure 1D). In
contrast to its potent proapoptotic effects on cDCs, IL-21 had
a weaker effect on pDC apoptosis (Figure 1E). Splenic cDCs
can be subdivided based on their CD8 expression (Liu and Nus-
senzweig, 2010). Both CD8+ and CD8 cDCs express IL-21R in
the steady state and it was induced by in vivo stimulation with
LPS (see Figures S1A–S1C available online). Moreover, IL-21-
induced apoptosis of both subpopulations of cDCs, and this
was reversed by GM-CSF (Figures S1D and S1E).
MHC class II and CD80 expression correlates with DC
maturation, and IL-21 can diminish MHC class II expression
on GMCSF-DCs (Brandt et al., 2003). Interestingly, IL-21 had
only modestly affected MHC class II and CD80 expression on
cDCs but had a potent effect on pDCs (Figure 1F, left panels,
ii versus i). GM-CSF had no obvious effect on MHC class II
expression (panels iii and iv) and did not affect its induction by
IL-21 (panels v and vi versus i and ii). GM-CSF appeared to
cooperate with IL-21 for CD80 induction on cDCs and pDCs
with somewhat higher MFIs with both cytokines than with
either alone (Figure 1F, right panels i–vi). Thus, in cDCs, GM-
CSF reversed IL-21-induced apoptosis but not its effect on
MHC class II and CD80 expression, suggesting that apoptosis
and maturation marker expression regulated by IL-21 involve
different pathways.
IL-21 and GM-CSF Have Distinctive and Overlapping
Effects on Gene Regulation
To study the mechanisms of IL-21-induced apoptosis of cDCs
and its prevention by GM-CSF, we used microarray analysis.
IL-21 induced 209 and repressed 85 genes R 1.5-fold at 5 hr
in splenic DCs (Figure 2A; Table S1), whereas GM-CSF induced
412 and repressed 269 genes at this time point (Figure 2A; TableS2). Both cytokines similarly regulated certain genes, including
inducing Socs1 and Socs3 and repressing Icosl and Il12b
(Figure 2B), while some genes were differentially regulated; for
example, IL-21 induced Il10 but not Ccl17 expression in splenic
DCs (Figure 2C), whereas GM-CSF induced Ccl17 but not Il10
(Figure 2C). Thus, IL-21 and GM-CSF have overlapping and
distinctive actions on splenic DCs.
GM-CSF Prevents IL-21-Induced Apoptosis by
Inhibiting Bim
We sought to identify genes induced by IL-21 but where the
induction was suppressed by GM-CSF, to potentially explain
the effects of these cytokines on apoptosis. GM-CSF inhibited
expression of 33 of the 209 genes induced by IL-21, including
Il21r and Bcl2l11 (which encodes Bim) (Tables S3 and S4).
Because Bcl-2 family proteins are implicated in IL-21-mediated
apoptosis in B cells (Jin et al., 2004; Mehta et al., 2003; Ozaki
et al., 2004), we focused on Bim. Consistent with the microarray
data, IL-21 did not significantly alter expression of Bcl2, Bclx, or
Bax (Figure 2D), but it significantly induced Bim messenger RNA
(mRNA) (Figure 2D) and protein, including both BimEL and BimL
isoforms (O’Connor et al., 1998) (Figure 2E), and GM-CSF in-
hibited this induction (Figures 2D and 2E). Moreover, the number
of cDCs was increased in Bcl2l11/ mice (Figure 2F) and
Bcl2l11/ cDCs exhibited lower IL-21-induced death (Figures
2G and 2H). Thus, GM-CSF inhibits IL-21-induced apoptosis
by decreasing the induction of Bim. Similar to the ability of IL-
21 to induce IL-21R in T cells (Zeng et al., 2005), IL-21 induced
Il21r expression in DCs, and this was inhibited by GM-CSF (Fig-
ure 2I), providing another mechanism for the effect of GM-CSF.
In contrast, IL-21 did not affect expression of the genes encoding
GM-CSF receptor a (Csf2ra) and bc (Csf2rb) (Figure 2I). Thus,
Bim is critical for IL-21-induced apoptosis of cDCs and its induc-
tion is inhibited by GM-CSF.
IL-21-Mediated Apoptosis of cDCs Requires STAT3
In T and B cells, IL-21 activates STAT1, STAT3, and STAT5, with
STAT3 activation being the most potent and sustained (Konforte
and Paige, 2006; Zeng et al., 2007). Similarly, in cDCs IL-21
induced phosphorylation of STAT1, STAT3, and weakly STAT5
within 10 min. By 90 min, phosphorylation of STAT1 and
STAT5 decreased but substantial STAT3 phosphorylation per-
sisted (Figure 3A). GM-CSF had only transient effects on
STAT1 and STAT3 phosphorylation, but as expected, it induced
sustained phosphorylation of STAT5 (Figure 3A). Although GM-
CSF inhibited IL-21-induced Il21r expression (Figure 2I), it did
not diminish IL-21-induced STAT3 phosphorylation (Figure 3A),
suggesting that GM-CSF does not affect proximal IL-21 sig-
naling. Consistent with IL-21 potently activating STAT3, after
deletion of Stat3 in DCs by crossing Stat3-floxed mice to
CD11c-Cre transgenic mice, IL-21 no longer increased
apoptosis or diminished viable cells (Figures 3B and 3C), nor
did it induce Il21r or Bcl2l11 (Figure 3D). However, STAT3 prob-
ably is not involved in DC development and maturation because
the number of splenocytes, cDCs, and pDCs were at most mini-
mally changed (Figures S2A–S2C), and expression of CD80,
CD86, ICOSL, and MHC class II was not altered (Figure S2D)
in mice in which Stat3 was conditionally deleted in DCs using
CD11c-Cre. Although IL-21-induced apoptosis in mantle cellImmunity 38, 514–527, March 21, 2013 ª2013 Elsevier Inc. 515
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Figure 1. IL-21 Strongly Induces Apoptosis of Splenic cDCs andModestly Affects pDCs, with Reversal of These Effects byGM-CSF, See Also
Figure S1
(A and B) Effect of IL-21 on viability of DCs. (A) GMCSF-DCs were rested 1 hr and stimulated with 1 mg/ml LPS and 200 nMCpG-Bwith or without 100 ng/ml IL-21
for 24 hr, and percent viable cells were determined by flow cytometry. (B) Splenic DCs were treated as in (A) for 6, 16, or 24 hr, and the number of DCs were
determined (means ± SEM from three experiments).
(C) Splenic DCs were rested 1 hr and not stimulated or stimulated with 20 ng/ml GM-CSF, 100 ng/ml Flt3L, 20 ng/ml IL-3, and 20 ng/ml IL-4 with or without
100 ng/ml IL-21 for 24 hr. cDCs and pDCs were identified by CD11c and B220 staining.
(legend continued on next page)
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Opposing IL-21 and GM-CSF Roles in DC Apoptosislymphoma depends on STAT1 (Gelebart et al., 2009), the weak
induction of STAT1 by IL-21 in DCs suggested that STAT1 might
not contribute to IL-21-induced apoptosis, and indeed, Stat1/
mice had essentially normal numbers of splenocytes, cDCs, and
pDCs (Figures S2E–S2G), and the lack of STAT1 did not prevent
IL-21-induced cell death (Figure 3E) nor substantially alter IL-21-
induced Il21r or Bcl2l11 expression (Figure 3F). Although IL-21
induced transient phosphorylation of STAT5, cDCs from
Stat5a/ mice exhibited more potent IL-21-induced apoptosis
and cell death (Figures 3G and 3H), as well as higher Il21r and
Bcl2l11 expression (Figure 3I), suggesting that STAT5 negatively
regulates IL-21’s action. Indeed, GM-CSF’s potent activation of
STAT5, a known survival factor (Debierre-Grockiego, 2004),
might explain the inhibitory effect of GM-CSF on IL-21-induced
apoptosis. Indeed, suppression of Bcl2l11 and Il21r by GM-
CSF was diminished in the absence of STAT5A (Figure 3I),
underscoring the ability of STAT5 to counteract IL-21’s effects
of DCs. These data indicate that STAT3 rather than STAT1 or
STAT5 mediates IL-21-induced apoptosis of cDCs.
IL-21-Induced STAT3 and GM-CSF-Induced STAT5
Compete for DNA Binding
We next used ChIP-Seq to examine STAT3 and STAT5 genome-
wide binding patterns in DCs in vivo. IL-21-induced STAT3 and
GM-CSF-induced STAT5 each broadly bound to intergenic
regions of DNA, introns, 50UTRs, and promoter regions, and
this distribution was not altered when IL-21 and GM-CSF were
combined (Figure 4A). However, GM-CSF reduced the number
of IL-21-induced STAT3 binding sites by 50% from 3,564 to
1,742, and IL-21 lowered GM-CSF-induced STAT5 binding
from 30,623 to 19,033 (Figure 4B). In the gene bodies of
Bcl2l11 and Il21r, GM-CSF induced the STAT5 binding at the
same loci where IL-21 induced STAT3 binding, and when IL-21
and GM-CSF were combined, the number of ChIP-Seq tags
decreased (Figure 4C), suggesting a competition between
STAT5 and STAT3 as one explanation for the ability of GM-
CSF to inhibit IL-21’s effect on DCs.
Cross Negative Regulatory Effect of IL-21 and GM-CSF
on DCs In Vivo
To study the effects of IL-21 and GM-CSF on DCs in vivo, we
used hydrodynamic injection (Liu et al., 1999) of Il21 and Csf2
(encodes GM-CSF) expression plasmids. GM-CSF expression
expands monocyte-derived proinflammatory DCs (mo-DCs)
in vivo (Naik et al., 2006), which resemble in vitro cultured
GMCSF-DCs. We distinguished cDCs and mo-DCs by CD64
expression, which is expressed in mo-DCs (CD64+ CD11chi)
but not cDCs (CD64CD11chi) (Langlet et al., 2012). IL-21 signif-
icantly reduced the number of cDCs (Figure 5A; Figure S3A) but
not pDCs (CD64 CD11cint Siglec H+) (Figures 5B; Figure S3A),
consistent with our in vitro observations, and GM-CSF partially(D) Splenic DCs were treated as in (C) for 6, 16, or 24 hr, and viable cells were cou
multiplying total cells by percentages of cDCs and pDCs from (C). Shown are m
(E) Splenic DCs were rested 1 hr, stimulated with indicated cytokines for 12 hr, a
staining. Data are representative of three experiments.
(F) Effect of IL-21 and GM-CSF on MHC class II and CD80 expression for cDCs a
experiments. Solid line represents mean florescence intensity (MFI) after cyto
expression as follows: cDCs = 145, pDCs = 34; and for CD80 expression as folloinhibited the effect of IL-21 on cDCs (Figure 5A; Figure S3A).
Interestingly, the number of mo-DCs expanded by GM-CSF
was significantly diminished by IL-21 (Figure 5C; Figure S3A),
confirming a previous in vitro study (Brandt et al., 2003). Thus,
IL-21 and GM-CSF have cross-regulatory effects.
We next sought to confirm that IL-21-induced cDC death
in vivo was also dependent on STAT3-mediated induction of
Bim. After hydrodynamic injection of Il21 plasmid, Bcl2l11 and
Il21r expression was increased in splenic DCs (Figure 5D) and
this inductionwas abolished in the absence of STAT3 (Figure 5E).
As expected, IL-21-induced Bcl2l11 expression and cDC death
were not observed in Il21r/ mice (Figures 5F–5H), and the
number of cDCs was not substantially decreased by expressing
IL-21 in animals lacking Bcl2l11 (Figures 5I and 5J), suggesting
that Bim is a critical mediator of cDC death. Interestingly, IL-
21-induced Il21r expression was higher in Bcl2l11/ than in
wild-type (WT) mice (Figure 5K). Consistent with Stat5a/
mice having enhanced IL-21-induced effects on cDCs in vitro
(Figures 3G–3I), injection of Il21 plasmid more strongly induced
Bcl2l11 expression in Stat5a/ than inWTmice (Figure 5L), sug-
gesting that STAT5A negatively regulated Bcl2l11 expression.
Correspondingly, IL-21 induced more cDC death in Stat5a/
than in WT mice (Figures 5M and 5N). These data indicate that
IL-21-induced cDC death in vivo requires expression of IL-21
receptor, STAT3, and Bim, and that STAT5 is a negative regu-
lator of IL-21’s effects.
To study the effects of IL-21 on CD8+ and CD8 cDC subsets
in vivo, we purified these subsets after injection of Il21 plasmid
(Figure S3B). IL-21 preferentially induced Il21r and Bcl2l11
expression in CD8 cDCs (Figure S3C) and correspondingly
induced death of CD8 but not CD8+ cDCs in vivo (Figure S3D).
Thus, although IL-21 induces apoptosis of both subtypes of
splenic cDCs with similar potency in vitro, the CD8 cDCs are
more sensitive to IL-21 in vivo.
Repetitive Stimulation of NKT Cells Leads to the IL-21-
Dependent DC Death
Activation of NKT cells by glycolipid a-galactosylceramide
(a-GalCer) induces production of IL-21 (Coquet et al., 2007),
which can induce Bε cell apoptosis and suppress IgE responses
(Harada et al., 2006). Whereas a single injection of a-GalCer into
mice activates DCs as reflected by increased MHC class II and
IL-12 expression, repetitive challenges of a-GalCer (three injec-
tions at intervals of 3–4 days) induces regulatory properties of
DCs, including production of IL-10 (Kojo et al., 2005). To study
the physiological role of IL-21 on DCs, we injected a-GalCer
once (GC1) or three times (GC3) into WTmice, and as previously
reported (Kojo et al., 2005), repetitive challenge of NKT cells
diminished Ifng but increased Il10 expression (Figure 6A). Inter-
estingly, a single injection of a-GalCer led to rapid induction
(4 hr) of Csf2, but this was greatly reduced with repetitivented by trypan blue exclusion; numbers of cDCs and pDCs were calculated by
eans ± SEM from three experiments.
nd the percentage of apoptotic cells was determined by Annexin V and 7-AAD
nd pDCs. Splenic DCs were treated as in (C). Data are representative of three
kine treatment. Dotted line represents MFI of untreated control for MHC II
ws: cDCs = 86, pDCs = 10.
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Figure 2. IL-21 and GM-CSF Have Both Distinctive and Overlapping Gene Regulation Profiles, See Also Tables S1, S2, S3, and S4
(A) Top shows the number of genes induced or repressed by IL-21, GM-CSF, or IL-21 + GM-CSF (R1.5-fold induction or repression with 10% FDR). Bottom
shows Venn diagrams that show numbers of genes induced or repressed by IL-21 and/or GM-CSF.
(B and C) IL-21 induces Socs1, Socs3, and Il10 and suppresses Icosl and Il12b, but does not affect Ccl17 expression. Splenic DCs were rested 1 hr and treated
with IL-21 and/or GM-CSF for 5 hr, and mRNA expression of indicated genes was analyzed by RT-PCR. Shown is expression relative to Rpl7; data are repre-
sentative of three experiments.
(D and E) IL-21 induced Bim, but this was inhibited by GM-CSF. (D) Splenic DCs were rested 1 hr and treated with IL-21 and/or GM-CSF for 5 hr, and mRNA
expression of Bcl2, Bclx, Bax, and Bcl2l11 was analyzed by RT-PCR. Shown is expression relative to Rpl7. Data are representative of three experiments.
(legend continued on next page)
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Figure 3. IL-21-Induced, STAT3-Dependent
Apoptosis and Induction of Bcl2l11 and
Il21r Expression, See Also Figure S2
(A) IL-21 activates STAT proteins in splenic DCs.
Splenic DCs were rested for 16 hr and stimulated
with indicated cytokines for 10 or 90 min. cDCs
were gated as CD11chi B220 cells. Phospho-
STAT1, STAT3, and STAT5 were evaluated by
flow cytometry. Data are representative of three
experiments.
(B–D) STAT3 is critical for IL-21-induced apoptosis
and for Bcl2l11 and Il21r expression. (B) Stat3-
CD11c-Cre conditionally-deficient mice and WT
littermates were treated as in Figure 2H, and
percentage of apoptotic cells was determined. (C)
Stat3-CD11c-Cre conditionally-deficient mice and
WT littermates were treated with IL-21 and/or
GM-CSF for 6, 16, or 24 hr, and viable cells were
determined. Data are representative of three
experiments. (D) Stat3-CD11c-Cre conditionally-
deficient mice and WT littermates were treated as
in Figure 2D, and Il21r (top) and Bcl2l11 (bottom)
levels were measured relative to Rpl7. Data are
representative of three experiments.
(E and F) STAT1 is not required for IL-21-induced
apoptosis or for expression of Bcl2l11 and Il21r.
(E) DCs from Stat1/ and WT littermates were
treated as in Figure 2G, and the number of viable
cells were counted. (F) Il21r (top) and Bcl2l11
(bottom) mRNA was measured as in (D). Data are
representative of three experiments.
(G–I) STAT5A is important of DC survival and for
suppression of Bcl2l11 and Il21r. (G) DCs from
Stat5a/ mice and WT littermates were treated
as in (B) and percentage of apoptotic cells was
determined. (H) Stat5a/ and WT mice were
treated as in (E), and the number of viable cells were
determined. (I) DCs from Stat5a/ mice and WT
littermates were rested 1 hr and then treated with
IL-21 and/or GM-CSF for 5 hr. mRNA expression of
Il21r (top) and Bcl2l11 (bottom) were measured as
in (D). Data are representative of three experiments.
In (C)–(F), (H), and (I), shown are means ± SEM.
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Opposing IL-21 and GM-CSF Roles in DC Apoptosischallenge (4 hr after the last injection). In contrast, Il21 expres-
sion was induced late (48 hr) after a single challenge, but induc-
tion was higher and more rapid after repetitive challenge (Fig-
ure 6A). Thus, repetitive stimulation of NKT cells potently
induced IL-21 but diminished GM-CSF production. Importantly,(E) Splenic DCs were treated as in (D) for 8 hr, and Bim levels were determined by immunoblotting; b-actin wa
experiments.
(F–H) Bcl211/ cDCs are resistant to IL-21-induced apoptosis. (F) Total splenic cDCs were higher in Bcl2l11
staining. Data are representative of three experiments. (G) Splenic DCs were not treated or were treated with
(H) Splenic DCs were treated with IL-21 for 20 hr and the percentage of apoptotic cells was determined.
(I) IL-21 induces Il21r expression, but this is inhibited byGM-CSF.mRNA expression of Il21r,Csf2a, andCsf2b
three experiments. In (B)–(D) and (F), (G), and (I), shown are means ± SEM.
Immunity 38, 514–52repetitive injection of a-GalCer not only
induced suppressive properties of DCs,
as reflected by expression of Il10 but not
Il12b, but it also induced Bcl2l11 and
Il21r expression (Figure 6B) anddecreased the number of CD8 but not CD8+ splenic DCs
(Figures 6C and 6D), consistent with the actions of IL-21 in vivo
(Figure S3D), and the decrease of CD8 DCs was attenuated
in the absence of IL-21 receptor or Bim (Figures 6E–6H). Thus,
repetitive antigen stimulation of NKT cells leads to increaseds a loading control. Data are representative of three
/mice. cDCs were identified by CD11c and B220
IL-21 for 6, 16, or 24 hr and viable cells determined.
weremeasured as in (B). Data are representative of
7, March 21, 2013 ª2013 Elsevier Inc. 519
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Figure 4. IL-21-Induced STAT3 and GM-
CSF-Induced STAT5 Compete for DNA
Binding
(A) Distribution of STAT3 and STAT5 binding sites
from ChIP-Seq analysis of splenic DCs treated
with IL-21 and/or GM-CSF for 2 hr.
(B) IL-21-induced STAT3 (left) and GM-CSF-
induced STAT5 (right) binding sites were lower in
DCs treated with GM-CSF + IL-21.
(C) STAT3 binding to Il21r and Bcl2l11 genes
was induced by IL-21 but inhibited by GM-CSF.
Tag numbers for peaks are indicated. Untreated
control showed minimal STAT3 binding. Data are
representative of two experiments.
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Opposing IL-21 and GM-CSF Roles in DC Apoptosisproduction of IL-21, which in turn regulates DC numbers via the
induction of Bim.
IL-21 Inhibits GM-CSF Production
Because GM-CSF inhibited the apoptotic effect of IL-21 on cDC,
and both GM-CSF and IL-21 are produced by activated CD4+
T cells, we asked whether IL-21 inhibited GM-CSF production.
Indeed, after TCR stimulation of CD4+ T cells for 4 hr, expression
of Csf2 was induced, but this was suppressed by IL-21 (Fig-
ure 7A; left). Interestingly, deletion of Stat3 in CD4+ T cells
increased TCR-induced Csf2 expression and abrogated IL-21-
mediated suppression (Figure 7A; left), suggesting that STAT3
inhibits Csf2 expression. Consistent with prior reports, IL-21
induced Il21 mRNA expression in WT (Korn et al., 2007; Nurieva
et al., 2008; Suto et al., 2008) but not in Stat3-deficient T cells
(Figure 7A; right) indicating that IL-21 autoregulation required
STAT3. Because IL-21-mediated STAT3 activation requires
JAK3 (Leonard and Spolski, 2005), we examined the effect of
a JAK3 inhibitor, CP-690550 (Changelian et al., 2003), on Csf2
expression. CP-690550 reduced TCR-induced Csf2 expression,520 Immunity 38, 514–527, March 21, 2013 ª2013 Elsevier Inc.but it abolished IL-21-mediated suppres-
sion of Csf2 (Figure 7B), confirming a role
for the JAK3-STAT3 pathway for this
effect. When we studied GM-CSF
production after 4 days of CD4+ T cell
differentiation in the presence of IL-21,
both mRNA and protein levels of GM-
CSFwere reduced even in Stat3-deficient
cells (Figure 7C; Figure S4A), suggesting
that IL-21 could also suppress GM-CSF
production independent of STAT3.
Because IFN-g, IL-12, and IL-27 can
negatively regulate GM-CSF production
in CD4+ T cells (Codarri et al., 2011), we
isolated T cells from WT mice or mice in
which Stat3 was deleted in T cells using
CD4-Cre and differentiated them in the
presence of IL-21 with or without
a mixture of blocking antibodies for IFN-
g, IL-12, and IL-27. These antibodies
indeed increased production of GM-
CSF, but IL-21 inhibited GM-CSF expres-
sion in the presence of these antibodies,
even in the absence of STAT3 (Figure 7D).Corresponding to the increased Csf2 mRNA in the absence of
STAT3 (Figure 7A), GM-CSF production increased in Stat3/
mice 4 days after TCR stimulation (Figure 7D; Figure S4B).
Thus, IL-21 can suppress GM-CSF production by a mechanism
independent of IFN-g, IL-12, and IL-27 as well as STAT3.
Furthermore, GM-CSF not only can block the actions of IL-21
in cDCs, but IL-21 can diminish the production of GM-CSF, indi-
cating cross-regulatory effects of these two cytokines.
IL-21 Decreases DC Numbers in T Cell Adoptive
Transfer-Mediated Colitis
To elucidate the functional role of IL-21 on DCs in a disease
setting, we used a T cell adoptive transfer colitis model. We
crossed Il21r/ mice with Rag2/ mice to generate mice lack-
ing expression of both Il21r and Rag2 and adoptively transferred
naive (CD25 CD45RBhi) WT CD4+ T cells into Il21r/Rag2/
orRag2/mice. We found that Il21r/Rag2/mice had earlier
weight loss than Rag2/ mice (Figure 7E), and their colons had
greater infiltration of mononuclear cells (Figure 7F, right panels),
inflammation, thickenedwalls, andepithelial damage (Figure 7G).
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Figure 5. IL-21-Induced cDC Death In Vivo Requires STAT3-Dependent Bim Expression, See Also Figure S3
(A–C) WT mice were injected i.v. with 10 mg of control (Ctrl), Il21 (IL-21), and/or Csf2 (GM) plasmids, and 48 or 72 hr later numbers of cDCs (A), pDCs (B), and
mo-DCs (C) were analyzed. Data are representative of three experiments with a total of 15 mice per group.
(D) WT mice were injected i.v. with control or Il21 plasmids as in (A). After 24 or 48 hr, splenic DCs were isolated and Il21r (left) and Bcl2l11 (right) mRNA levels
assessed. (E) Stat3-CD11c-Cre conditionally-deficient mice and WT littermates were treated as in (A) for 24 hr, splenic DCs were isolated, and Il21r (left) and
Bcl2l11 (right) mRNA levels were assessed.
(F–H) Il21r/ and WT littermates were treated as in (A) for 48 hr, splenic DCs were isolated, and Il21r (left) and Bcl2l11 (right) mRNA levels were assessed (F).
Absolute number (G) and relative percentage based on MHCII and CD11c expression (H) of cDCs were determined.
(legend continued on next page)
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Immunity
Opposing IL-21 and GM-CSF Roles in DC ApoptosisThe morphology of colons from Il21r/Rag2/ mice that did
not receive WT CD4+ T cells was normal (Figure 7F, left panels);
thus, the inflammation depended on donor T cells. When naive
CD4+ T cells isolated from Il21-mCherry transgenic reporter
mice (Wang et al., 2011) were injected into Rag2/ and Il21r/
Rag2/mice, the percentage of T cells that expressed mCherry
tended to be higher in Il21r/Rag2/ than in Rag2/mice, but
the difference was not statistically significant (Figure 7H). GM-
CSF was also produced by these cells but its expression level
was much lower than IL-21 (Figure 7H), suggesting that IL-21
might be critical for the observed pathology. Consistent with
the actions of IL-21 on DCs, colons from Il21r/Rag2/ mice
had more DCs than those from Rag2/ mice (Figure 7I). DC-T
cell interactions are critical for T cell expansion, differentiation,
and function and consistent with more severe disease in the
Il21r/Rag2/ mice, after adoptive transfer these animals
had increased CD4+ T cells in colon (Figure 7J) and mesenteric
lymph nodes (Figure 7K). After stimulation with PMA + ionomy-
cin, CD4+ T cells from Il21r/Rag2/ mice expressed less IL-
17 but more IFN-g than did cells from Rag2/ mice (Figure 7L),
indicating increased Th1 differentiation, consistent with the
importance of IFN-g in colitis progression (Bouma and Strober,
2003). These data suggested a physiological significance of
IL-21 on DC turnover and T cell-mediated pathology.
DISCUSSION
In this study, we unexpectedly found that IL-21 has markedly
different effects on cDCs and pDCs, inducing a greater decrease
in viability and corresponding increase in apoptosis of cDCs than
in pDCs, while more potently inducing MHC II expression on
pDCs than on cDCs. IL-21 was previously reported to inhibit
LPS-induced production of IL-12, TNF-a, and IL-6 in GMCSF-
DCs (Brandt et al., 2003). Our demonstration that IL-21-induced
apoptosis of cDCs is prevented by GM-CSF reveals at least
partially opposing biological actions by these cytokines. Indeed,
the inhibitory action of GM-CSF helps to explain the lack of IL-
21-induced cell death in GMCSF-DCs. By microarray analysis,
we found that GM-CSF inhibited a subset of the genes induced
by IL-21, including Il21r and Bcl2l11, whereas other genes were
induced (e.g., Socs3, Socs1) or inhibited (e.g., Icosl, Il12b) by
both IL-21 and GM-CSF, revealing that IL-21 and GM-CSF
have overlapping but also distinctive effects. ChIP-Seq analysis
for STAT3 and STAT5 in splenic DCs treated with IL-21 and GM-
CSF revealed that the number of STAT3 sites and the intensity of
binding were reduced in the presence of GM-CSF, suggesting
that binding competition between STAT3 and STAT5 may be
a mechanism by which GM-CSF might inhibit IL-21-induced
gene expression and biological actions.
We show that IL-21 induces apoptosis of cDCs via STAT3-
dependent induction of Bim, even though IL-21-activated
STAT3 is generally viewed as a positive regulator of T cell
development and function (e.g., deletion of STAT3 in CD4+
T cells prevents the development of inflammatory bowel disease(I–K) Bcl2l11/ mice and WT littermates were treated as in (A) for 48 hr, splenic D
were determined. Il21r (left) and Bcl2l11 (right) mRNA levels were assessed (K).
(L–N) Stat5a/ and WT control mice were treated as in (A) for 48 hr, splenic DCs
relative percentage (N) of cDCs were determined. In (D)–(N), data from two expe
522 Immunity 38, 514–527, March 21, 2013 ª2013 Elsevier Inc.[Durant et al., 2010]). However, several studies showed that
STAT3 activation negatively regulates DC function (Cheng
et al., 2003; Melillo et al., 2010; Nefedova et al., 2005), and
inhibiting STAT3 can increase the ability of DCs to stimulate allo-
geneic or antigen-specific T cells (Nefedova et al., 2005). Impor-
tantly, mice in which Stat3 was conditionally deleted using
CD11c-Cre develop cervical lymphadenopathy and mild ileoco-
litis, and DCs from these mice have enhanced immune activity
(Melillo et al., 2010). Our findings may explain these observa-
tions, with IL-21-induced STAT3-dependent apoptosis of cDCs
providing a mechanism for limiting immune responses. Indeed,
apoptosis of DCs is critical for preventing autoimmunity upon
challenge by pathogens, and mice bearing apoptosis-resistant
DCs exhibit chronic lymphocyte activation and systemic autoim-
mune disease (Chen et al., 2006). The production of IL-21may be
a way to eliminate DCs, thus maintaining immune tolerance.
Importantly, however, IL-21 can positively regulate autoimmu-
nity in the context of type 1 diabetes (McGuire et al., 2011;
Spolski et al., 2008; Sutherland et al., 2009) and systemic lupus
erythematosus (Bubier et al., 2009; Herber et al., 2007; Ozaki
et al., 2004), indicating critical roles for IL-21 in vivo. Given that
DCs might receive multiple cytokine signals simultaneously,
the ability of GM-CSF to inhibit IL-21-induced apoptosis was
striking. Indeed, cDCs produce IL-6 after IL-21 stimulation
(Spolski et al., 2012) and the induction is not inhibited by GM-
CSF (Table S3), suggesting that GM-CSF might switch the role
of IL-21 to cDCs from anti-inflammatory to proinflammatory.
Moreover, we showed not only that GM-CSF inhibits IL-21-
mediated apoptosis, but that IL-21 inhibits the production of
GM-CSF, indicating a fine-tuning of actions via a cross-negative
regulation. Importantly, repetitive injection of mice with a-GalCer
induced IL-21 and decreased GM-CSF production by NKT cells,
as well as increased Il21r and Bcl2l11 expression by cDCs,
correlating with a reduction in the number of these cells, and
furthermore data in the colitis model revealed greater numbers
of colonic DCs in Rag2/Il21r/ than in Rag2/ mice, with
an associated increase in pathology.
Previously, it was shown that IL-21 cooperates with IL-15 to
enhance CD8+ T cell expansion and function (Zeng et al.,
2005) and with IL-4 to induce antigen-specific IgG production
(Ozaki et al., 2002). Our current study identifies distinctive roles
for IL-21 depending on the type of DCs and reveals that GM-
CSF can potently inhibit IL-21-mediated effects on cDCs. Given
the critical roles served by DCs in immune responses, our eluci-
dation of the actions of IL-21 and GM-CSF on DCs have impli-
cations for the rational design of strategies for modulating
immune responses and new treatments of immune-related
diseases.EXPERIMENTAL PROCEDURES
Mice
C57BL/6, Rag2/, Bcl2l11/ (Bouillet et al., 1999), and CD11c-Cre (Caton
et al., 2007) mice were from The Jackson Laboratory. Il21r/ (Ozaki et al.,Cs were isolated and absolute number (I) and relative percentage (J) of cDCs
were isolated, and Bcl2l11mRNA was assessed (L). Absolute number (M) and
riments were combined, with a total of 5–6 mice per group.
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Figure 6. IL-21 Produced by NKT Cells Induces DC Death
(A) Mice were injected with a-GalCer once (GC1) or three times (GC3), splenic NKT cells (pooled from three mice) were isolated 4 or 48 hr after the last injection,
and mRNA expression of indicated genes was analyzed. Expression levels are relative to Rpl7 (mean ± SEM) and representative of three experiments.
(B) Mice were injected with a-GalCer three times, splenic DCs were isolated 4 hr after the last injection, and mRNA expression of indicated genes was analyzed
relative to Rpl7.
(C and D) Mice were challenged as in (B), total spleen cells were harvested 48 hr after the last injection, and the relative percentage (C) and absolute number (D) of
total CD8 or CD8+ cDCs were determined. Data are from two experiments with a total of six mice per group.
(E and F) WT or Il21r/ mice were treated as in (B), total spleen cells were harvested 48 hr after the last injection, and the relative percentage (E) and absolute
number (F) of total CD8 or CD8+ cDCs were determined. Data are from two experiments with a total of six mice per group.
(G and H) WT or Bcl2l11/mice were treated as in (B), total spleen cells were harvested 48 hr after the last injection, and the relative percentage of cDCs (G) and
number of total cDCs and CD8 or CD8+ subpopulations of cDCs (H) were determined. Data are from two experiments with a total of five mice per group.
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Figure 7. Reciprocal Production of IL-21 and GM-CSF and Its Physiological Significance, See Also Figure S4
(A–D) IL-21 inhibits GM-CSF production in CD4+ T cells. (A) CD4+ T cells from WT or Stat3-CD4-Cre conditionally-deficient mice were treated with 5 mg/ml
plate-bound anti-CD3 and 2 mg/ml soluble anti-CD28 without or with 100 ng/ml IL-21 for 4 hr. mRNA expression of Csf2 (left) and Il21 (right) was measured.
Data are representative of three experiments. (B) CD4+ T cells from WT mice were treated as in (A) with or without 10 mM of CP-690550, and Csf2
mRNA expression was measured. Data are representative of three experiments. (C and D) CD4+ T cell differentiation with IL-21 diminishes GM-CSF
production independent of STAT3, IFN-g, IL-12, and IL-27 signaling. (C) Naive CD4+ T cells from WT or Stat3-CD4-Cre conditionally-deficient mice were
cultured with 5 mg/ml plate-bound anti-CD3 and 2 mg/ml anti-CD28 without or with 100 ng/ml IL-21 for 4 days, then washed and restimulated with
PMA + ionomycin for 4 hr, and IL-21 (Il21) or GM-CSF (Csf2) mRNA were measured. Data are representative of three experiments. (D) CD4+ T cells
were differentiated as in (C) without or with 10 mg/ml of anti-IFN-g, anti-IL-12, and anti-IL-27 for 4 days. Cells were washed and restimulated with
PMA + ionomycin and golgiplug for 4 hr, and intracellular GM-CSF was analyzed by flow cytometry. Data are representative of three experiments. In (A)–(C),
shown are means ± SEM.
(legend continued on next page)
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been described. In some experiments, control mice were from Taconic.
Il21-mCherry reporter transgenic mice were described (Wang et al.,
2011). STAT3-deficient DCs or CD4+ T cells were generated by crossing
Stat3-floxed mice (Lee et al., 2002) with CD11c-Cre or CD4-Cremice, respec-
tively. Stat1/ and control mice on a 129S6 background were from Taconic
Farms. Il21r/ and Rag2/ mice were bred to generate Il21r/Rag2/
mice. All protocols were approved by the NHLBI Animal Care and Use
Committee and followed NIH guidelines for using animals in intramural
research.
Isolation of Splenic DCs
Mouse spleens were injected with 1 ml of 1 mg/ml collagenase D and 20 mg/ml
DNase I (Roche), cut, and incubated in collagenase solution at 37C for 20min.
After passage through a cell strainer, red blood cells were lysed using ACK
lysis buffer, and remaining cells incubated with Fc block (BD Biosciences) at
4C for 10 min. CD11c+ cells were positively selected with pan-DC or
CD11c microbeads (Miltenyi Biotec). Purity of CD11c+ DCs was 93%–95%.
pDCs (CD11cloB220+PDCA-1+) were 3%–10% of DCs isolated with pan-DC
microbeads.
In Vivo Administration of a -GalCer and the Isolation of Splenic NKT
Cells
Mice were injected intraperitoneally (i.p.) with 2 mg of a-GalCer (Enzo Life
Sciences) either once (GC1) or three times at intervals of 3 days (GC3). Four
or 48 hr after the last injection, spleens from three mice were pooled and
NKT cells were isolated with NK1.1+ iNKT cell isolation kit (Miltenyi Biotec).
Generation of GMCSF-DCs
Bone-marrow cells from mouse femurs and tibias were cultured for 8 days in
RPMI-1640 medium containing 10% FBS, 200 mM L-glutamine, 10 IU/ml
penicillin, 100 mg/ml streptomycin, 55 mM b-mercaptoethanol, and 20 ng/ml
GM-CSF (Peprotech), with medium changed every 3 days. CD11c+ DCs
were >90% pure.
Cell Viability and Apoptosis Studies
Splenic DCs or GMCSF-DCs were rested at 37C for 1 hr and treated with
cytokines for 6, 16, and 24 hr. The number of DCs was counted, and cDCs
and pDCs were distinguished by staining for B220, CD8, and CD11c. For
apoptosis, cells were stained with Annexin V and 7-AAD (BD Biosciences).
Data in viability studies are mean ± SEM fromR3 experiments.
FACS Analysis of Phosphorylated STAT Proteins
To reduce the background p-STAT signal, splenic DCs in complete medium
were rested at 37C for 16 hr, stained with anti-CD11c-APC and anti-B220-
FITC at 37C for 10 min, stimulated with cytokines for indicated time, fixed
with 2% paraformaldehyde at 37C for 10 min, and permeabilized in 90%
ice-cold methanol for 30 min. After two washes with FACS buffer (PBS with
1% FBS), cells were stained with p-STAT1 (Y701)-PE, p-STAT3 (Y705)-PE,
or p-STAT5 (Y694)-Alexa Fluor 647 antibodies at RT for 1 hr and analyzed
on a FACSCalibur.
RNA Analysis
Total RNA was isolated using the RNeasy Plus Mini Kit (QIAGEN). First-strand
complementary DNAs (cDNAs) were synthesized using the Omniscript reverse(E–L) Naive (CD25 CD45RBhi) CD4+ T cells from C57BL/6 mice were injected into
loss than Rag2/ mice. Data are representative of four experiments with >5 m
showed significant weight loss, fixed with 10% formalin, and paraffin sections w
controls. (G) Colon pathology scores were based on severity of mononuclear cell
and epithelial damage, including edema, degeneration, and necrosis. Scores are
Naive CD4+ T cells from Il21-mCherry reporter transgenic mice were injected intoR
IL-21 (based onmCherry) and GM-CSF (by intracellular staining) was analyzed by
from Rag2/ and Il21r/Rag2/ mice were isolated when Il21r/Rag2/ mic
cytometry. (J) Relative percentage of CD4+ T cells in colon and (K) mesenteric lym
were stimulated with 50 ng/ml PMA + 1 mg/ml ionomycin and golgiplug for 4 hr.
Graphs are representative ofR8 mice per group.transcription kit (QIAGEN) and oligo(dT). Quantitative RT-PCR was performed
on a 7900H sequence detection system (Applied Biosystems). Real-time
primers and TaqMan probes were from Applied Biosystems. Expression
was normalized to Rpl7.
Immunoblot Analysis
Purified splenic DCs were rested 1 hr, then left unstimulated or stimulated with
IL-21 and/or GM-CSF for 8 hr, lysed in RIPA buffer (Thermo Scientific) for
15 min, and 5 mg cell lysate protein was resolved by 4%–12% SDS-PAGE
and immunoblotted with anti-Bim (Millipore) or anti-b-actin (Santa Cruz
Biotechnology).
Th Cell Polarization
Naive (CD62L+ CD44 CD25) CD4+ T cells were negatively selected from
splenic CD4+ T cells, followed by positively selecting CD62L+ cells (Miltenyi
Biotec), cultured for 4 days with 5 mg/ml plate-bound anti-CD3 + 2 mg/ml
anti-CD28 in the presence of IL-21 (R & D Systems), washed, and restimulated
with 50 ng/ml PMA + 1 mM ionomycin for 4 hr to measure mRNA expression,
or 2 mg/ml anti-CD3 for 24 hr to measure GM-CSF protein by ELISA
(BD Biosciences).
Hydrodynamic Injected-Mediated Expression of Cytokines In Vivo
Experiments were done as described (Liu et al., 1999). Control, Csf2 (from
Howard Young, NIH), and Il21 (Invivogen) expression plasmids were prepared
by EndoFree Plasmid Mega Kit (QIAGEN). Mice were injected intravenously
(i.v.) with 10 mg plasmid DNA in 1.5 ml PBS. Splenic DCs were analyzed
24 to 72 hr postinjection.
Adoptive Transfer of Naive CD4+ T Cells and Cell Isolation from
Colons
Splenic CD4+ T cells were isolated by negative selection using CD4+ T cell
isolation kit (Miltenyi Biotec), stained with antibodies to CD4, CD25, and
CD45RB and CD4+CD25CD45RBhi (brightest 40%) cells sorted by flow
cytometry. We injected 4 3 105 cells i.p. into Rag2/ or Il21r/Rag2/
mice. Mice were weighed periodically and analyzed when the Il21r/Rag2/
mice showed significant weight loss. Total colon cells (without lymphocyte
enrichment) were isolated as described (Kitamura et al., 2010).
Microarray and Data Analysis
One mg total RNA was incubated with oligo dT/T7 primers and reverse tran-
scribed into doubled-stranded cDNA. In vitro transcription and biotin labeling
were performed with T7 RNA polymerase at 37C for 16 hr (Affymetrix IVT
labeling kit). Twenty mg of this biotin-labeled RNA was fragmented to
200 bp by incubating in 200 mM Tris-acetate pH 8.2, 500 mM potassium
acetate and 500 mM magnesium acetate for 35 min at 94C and then hybrid-
ized to Affymetrix U133 plus 2.0 chips for 16 hr, washed, and stained on an
Affymetrix fluidics station. Affymetrix GCOS version 1.4 was used to calculate
the signal intensity and percent present calls. Signal-intensity values for probe
sets were transformed using an adaptive variance-stabilizing, quantile-
normalizing transformation, and data from the chips were subjected to a
principal component analysis (PCA) to detect outliers, and fold-cut off and
false discovery rate (FDR) analysis filters were applied. To bring together
sets of samples and genes with similar expression patterns, two-way hierar-
chical clustering was run using the JMP5.1 statistical software package
(SAS Institute) and the Ward method.Rag2/ or Il21r/Rag2/mice. (E) Il21r/Rag2/mice had earlier weight
ice per experiment. (F) Colons were removed when the Il21r/Rag2/ mice
ere stained with hematoxylin and eosin. Colons from untransferred mice were
inflammation, intestinal wall thickening, including infiltration to the muscularis,
as follows: 0 = normal, 0.5 = very mild, 1 = mild, 2 = moderate, 3 = severe. (H)
ag2/ and Il21r/Rag2/mice, colon cells were isolated, and expression of
flow cytometry. Graphs are representative of five mice per group. (I) Colon cells
e showed significant weight loss, and percentage of DCs determined by flow
ph nodes (mLN) was determined by flow cytometry. (L) Colon and mLN cells
Intracellular IFN-g and IL-17 in CD4+ T cells were analyzed by flow cytometry.
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Splenic DCs were rested for 1 hr, treated with cytokines for 2 hr, and fixed with
1% formaldehyde at 37C for 10 min. Chromatin from 5 3 107 cells was soni-
cated for 20 cycles of 12 s on/48 s off, into 200–500 bp fragments, DNA ends
were repaired using polynucleotide kinase and Klenow enzyme, and treated
with Taq polymerase to generate a protruding 30 ‘‘A’’ nucleotide. A pair of
Solexa PE adaptors (Illumina) was ligated and DNA amplified using the adaptor
primers (PE 1.0 and 2.0, Illumina) for 19 cycles. DNA fragments of
250–450 bp were purified from agarose gels and used for cluster generation
and sequencing (Solexa 1G Genome Analyzer). Anti-STAT3 antibody
(13–7,000, Invitrogen) and anti-STAT5 (PA-ST5B, R&D Systems) were used.
Sequenced short reads (typically 25 bp) were obtained with the Solexa
Analysis Pipeline and mapped to the mouse genome (mm8/NCBI36, 2006
Assembly), retaining only uniquely matched reads. To eliminate bias caused
by PCR amplification, we also removed redundant reads at specific genomic
coordinates. The Pipeline output was converted to browser-extensible data
(BED) files for viewing on the UCSC genome browser (http://genome.ucsc.
edu/). BED files represent the genomic coordinates of each read; to make
graph files, we mapped reads into nonoverlapping 200 bp windows. The loca-
tion of a tag on ± strand was shifted by up to ± 100 bp from its 50 start to repre-
sent the center of the DNA fragment associated with the read. Reads in each
200 bp summary window were counted.
Genomic regions enriched for GM-CSF-induced STAT5B and IL-21-
induced STAT3 binding were detected using the model-based analysis of
ChIP-Seq (MACS, version 1.3.7.1) algorithm (Zhang et al., 2008), using gsize =
2.04e+09,mfold = 15, tsize = 25, bw = 300, pvalue = 1.0e-05. Final peaks were
filtered by FDR = 0.02. Our ChIP-Seq data were saturating (i.e., adding more
reads would not detect more peaks). To determine STAT3 and STAT5B
binding site distribution, based on UCSC genes annotations database, we
divided the mouse genome into six regions: promoters (from transcriptional
start sites [TSS] to 5 kb 50 of TSS), 50 UTR (50 untranslated region, from TSS
to coding region start), exons, introns, 30 UTR, and intergenic regions.
Statistical Analysis
Statistical comparison between samples was done by Student’s t test.
*, p < 0.05; **, p < 0.01. NS, not statistically different.
ACCESSION NUMBERS
Microarray and short reads from ChIP-Seq data are accessible through GEO
SuperSeries accession number GSE27161 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cg?acc=GSE27161).
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